This is not the most recent version of the article. View current version (20 JAN 2010)

Intervention Protocol

Amisulpride versus other atypical antipsychotics for schizophrenia

  1. Katja Komossa1,*,
  2. Christine Rummel-Kluge1,
  3. Heike Hunger1,
  4. Franziska Schmidt1,
  5. Sandra Schwarz1,
  6. Joaquim I Silveira da Mota Neto2,
  7. Werner Kissling3,
  8. Stefan Leucht1

Editorial Group: Cochrane Schizophrenia Group

Published Online: 7 OCT 2009

DOI: 10.1002/14651858.CD006624

How to Cite

Komossa K, Rummel-Kluge C, Hunger H, Schmidt F, Schwarz S, Silveira da Mota Neto JI, Kissling W, Leucht S. Amisulpride versus other atypical antipsychotics for schizophrenia (Protocol). Cochrane Database of Systematic Reviews 2007, Issue 3. Art. No.: CD006624. DOI: 10.1002/14651858.CD006624.

Author Information

  1. 1

    Technische Universität München Klinikum rechts der Isar, Klinik und Poliklinik für Psychiatrie und Psychotherapie, München, Germany

  2. 2

    Universidade Federal de Pelotas, Evidence Based Medicine Centre, Pelotas, Brazil

  3. 3

    Technische Universität München Klinikum rechts der Isar, Klinik und Poliklinik für Psychiatrie und Psychotherapie , München, Germany

*Katja Komossa, Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, Moehlstrasse 26, München, 81675, Germany. k.komossa@lrz.tu-muenchen.de.

Publication History

  1. Publication Status: Unchanged
  2. Published Online: 7 OCT 2009

SEARCH

This is not the most recent version of the article.View current version (20 Jan 2010)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To review the effects of amisulpride compared with other new generation antipsychotics for people with schizophrenia.